Cargando…

Diagnosis and treatment outcomes from prebronchodilator spirometry performed alongside lung cancer screening in a Lung Health Check programme

INTRODUCTION: Incorporating spirometry into low-dose CT (LDCT) screening for lung cancer may help identify people with undiagnosed chronic obstructive pulmonary disease (COPD), although the downstream impacts are not well described. METHODS: Participants attending a Lung Health Check (LHC) as part o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bradley, Claire, Boland, Alison, Clarke, Louisa, Dallinson, Naomi, Eckert, Claire, Ellames, Deborah, Finn, Jonathan, Gabe, Rhian, Hancock, Neil, Kennedy, Martyn PT, Lindop, Jason, Mohamed, Ayad, Mullen, Gabriel, Murray, Rachael L, Rogerson, Suzanne, Shinkins, Bethany, Simmonds, Irene, Upperton, Sara, Wilkinson, Anne, Crosbie, Philip A, Callister, Matthew EJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314060/ https://www.ncbi.nlm.nih.gov/pubmed/36972979 http://dx.doi.org/10.1136/thorax-2022-219683

Ejemplares similares

Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes
por: Fortis, Spyridon, et al.
Publicado: (2017)

Prevalence and risk factors for COPD in subjects with preserved ratio impaired spirometry
por: Kanetake, Rina, et al.
Publicado: (2022)

Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD
por: Bradley, Claire, et al.
Publicado: (2023)

Undiagnosed and ‘overdiagnosed’ COPD using postbronchodilator spirometry in primary healthcare settings: a systematic review and meta-analysis
por: Perret, Jennifer, et al.
Publicado: (2023)

Clinical features and 1-year outcomes of chronic bronchitis in participants with normal spirometry: results from the ECOPD study in China
por: Wu, Fan, et al.
Publicado: (2023)

Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study
por: Heraganahally, Subash S, et al.
Publicado: (2021)

Genetic variants affecting cross-sectional lung function in adults show little or no effect on longitudinal lung function decline
por: John, Catherine, et al.
Publicado: (2017)

Driving performance in patients with chronic obstructive lung disease, interstitial lung disease and healthy controls: a crossover intervention study
por: Skovhus Prior, Thomas, et al.
Publicado: (2015)

Aclidinium inhibits human lung fibroblast to myofibroblast transition
por: Milara, Javier, et al.
Publicado: (2011)

Targeted lung denervation for moderate to severe COPD: a pilot study
por: Slebos, Dirk-Jan, et al.
Publicado: (2015)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease
por: Annangi, Srinadh, et al.
Publicado: (2022)

Physiological changes related to 10 weeks of singing for lung health in patients with COPD
por: Kaasgaard, Mette, et al.
Publicado: (2022)

Patient experience of COPD care: outcomes from the British Lung Foundation Patient Passport
por: Philip, Keir, et al.
Publicado: (2019)

Attitudes and access to lung volume reduction surgery for COPD: a survey by the British Thoracic Society
por: McNulty, William, et al.
Publicado: (2014)

Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial
por: Deslee, Gaëtan, et al.
Publicado: (2014)

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
por: Mayhew, David, et al.
Publicado: (2018)

Diagnoses and treatments for participants with interstitial lung abnormalities detected in the Yorkshire Lung Screening Trial
por: Upperton, Sara, et al.
Publicado: (2023)

The physiology of singing and implications for ‘Singing for Lung Health’ as a therapy for individuals with chronic obstructive pulmonary disease
por: Lewis, Adam, et al.
Publicado: (2021)

Smoking and socioeconomic factors linked to acute exacerbations of COPD: analysis from an Asthma + Lung UK survey
por: Williams, Parris J, et al.
Publicado: (2022)

Assessment of lung hyperinflation in occupational chronic obstructive pulmonary disease: a multicentric cross-sectional study
por: de Broucker, Virginie, et al.
Publicado: (2023)

Higher BMI is associated with higher expiratory airflow normalised for lung volume (FEF25–75/FVC) in COPD
por: Abston, Eric, et al.
Publicado: (2017)

Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung
por: Segal, Leopoldo N, et al.
Publicado: (2017)

Examining the possible causal relationship between lung function, COPD and Alzheimer’s disease: a Mendelian randomisation study
por: Higbee, Daniel, et al.
Publicado: (2021)

Nationwide indoor smoking ban and impact on smoking behaviour and lung function: a two-population natural experiment
por: Strassmann, Alexandra, et al.
Publicado: (2023)

Lung volumes identify an at-risk group in persons with prolonged secondhand tobacco smoke exposure but without overt airflow obstruction
por: Arjomandi, Mehrdad, et al.
Publicado: (2018)

Effect of β-blockade on lung function, exercise performance and dynamic hyperinflation in people with arterial vascular disease with and without COPD
por: Key, Angela, et al.
Publicado: (2017)

Fast decliner phenotype of chronic obstructive pulmonary disease (COPD): applying machine learning for predicting lung function loss
por: Nikolaou, Vasilis, et al.
Publicado: (2021)

Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema
por: Mimae, Takahiro, et al.
Publicado: (2014)

Study investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect
por: Pate, Alexander, et al.
Publicado: (2018)

Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial
por: Frith, Peter A, et al.
Publicado: (2015)

Self-management programme of activity coping and education—SPACE for COPD(C)—in primary care: a pragmatic randomised trial
por: Bourne, Claire, et al.
Publicado: (2022)

Visual rating assessment of cerebral atrophy and its relationship with cognitive function in chronic obstructive pulmonary disease
por: Savage, Charlotte Claire, et al.
Publicado: (2018)

Endobronchial valves for emphysema: an individual patient-level reanalysis of randomised controlled trials
por: Klooster, Karin, et al.
Publicado: (2017)

The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference
por: Nolan, Claire M, et al.
Publicado: (2016)

Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study
por: Maddocks, Matthew, et al.
Publicado: (2016)

High-pressure NIV for acute hypercapnic respiratory failure in COPD: improved survival in a retrospective cohort study
por: Hedsund, Caroline, et al.
Publicado: (2022)

Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France
por: Whittaker, Hannah, et al.
Publicado: (2022)

Home-based pulmonary rehabilitation early after hospitalisation in COPD (early HomeBase): protocol for a randomised controlled trial
por: Cox, Narelle S, et al.
Publicado: (2021)

Increased expression of placenta growth factor in COPD
por: Cheng, S-L, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_j5uj81gea1i7dg6p3i31kd0fk6